These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10976611)

  • 61. Health behaviors of young adult heroin injectors in the Seattle area.
    Cedarbaum ER; Banta-Green CJ
    Drug Alcohol Depend; 2016 Jan; 158():102-9. PubMed ID: 26651427
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Syringe access programs.
    J Assoc Nurses AIDS Care; 2012; 23(3):272-4. PubMed ID: 22645744
    [No Abstract]   [Full Text] [Related]  

  • 63. Prison-based syringe exchange programmes: a review of international research and development.
    Dolan K; Rutter S; Wodak AD
    Addiction; 2003 Feb; 98(2):153-8. PubMed ID: 12534419
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Health services utilization by injection drug users participating in a needle exchange program.
    Riley ED; Wu AW; Junge B; Marx M; Strathdee SA; Vlahov D
    Am J Drug Alcohol Abuse; 2002; 28(3):497-511. PubMed ID: 12211362
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation.
    Safaeian M; Brookmeyer R; Vlahov D; Latkin C; Marx M; Strathdee SA
    Am J Epidemiol; 2002 Jan; 155(2):169-75. PubMed ID: 11790681
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Needle exchange program attendance and injection risk in Providence, Rhode Island.
    Longshore D; Bluthenthal RN; Stein MD
    AIDS Educ Prev; 2001 Feb; 13(1):78-90. PubMed ID: 11252456
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interest in Getting Help to Reduce or Stop Substance Use Among Syringe Exchange Clients Who Use Opioids.
    Frost MC; Williams EC; Kingston S; Banta-Green CJ
    J Addict Med; 2018; 12(6):428-434. PubMed ID: 29889118
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Needling Policy Makers and Sharpening the Debate: Do Syringe Exchange Programs Improve Health at the Population Level?
    Motie I; Carretta HJ; Beitsch LM
    J Public Health Manag Pract; 2020; 26(3):222-226. PubMed ID: 32235205
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Psychiatric distress, risk behavior, and treatment enrollment among syringe exchange participants.
    Kidorf M; King VL; Peirce J; Burke C; Kolodner K; Brooner RK
    Addict Behav; 2010 May; 35(5):499-503. PubMed ID: 20079972
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risk factors for nonfatal overdose at Seattle-area syringe exchanges.
    Jenkins LM; Banta-Green CJ; Maynard C; Kingston S; Hanrahan M; Merrill JO; Coffin PO
    J Urban Health; 2011 Feb; 88(1):118-28. PubMed ID: 21246299
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beyond equipment distribution in Needle and Syringe Programmes: an exploratory analysis of blood-borne virus risk and other measures of client need.
    Treloar C; Mao L; Wilson H
    Harm Reduct J; 2016 May; 13(1):18. PubMed ID: 27246345
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Selective risk taking among needle exchange participants: implications for supplemental interventions.
    Valente TW; Vlahov D
    Am J Public Health; 2001 Mar; 91(3):406-11. PubMed ID: 11236405
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A pilot syringe exchange program in Washington, DC.
    Vlahov D; Ryan C; Solomon L; Cohn S; Holt MR; Akhter MN
    Am J Public Health; 1994 Feb; 84(2):303-4. PubMed ID: 8296961
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Benefits of concurrent syringe exchange and substance abuse treatment participation.
    Kidorf M; King VL; Peirce J; Kolodner K; Brooner RK
    J Subst Abuse Treat; 2011 Apr; 40(3):265-71. PubMed ID: 21255959
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program.
    Des Jarlais DC; Fisher DG; Newman JC; Trubatch BN; Yancovitz M; Paone D; Perlman D
    Am J Public Health; 2001 Nov; 91(11):1791-2. PubMed ID: 11684603
    [No Abstract]   [Full Text] [Related]  

  • 76. Examining Social-Ecological Factors in Developing the Louisville Metro Department of Public Health and Wellness Syringe Exchange Program.
    Kerr J; Atlas M; Crabtree W; Chen YT; Moyer S
    Am J Public Health; 2019 Mar; 109(3):454-457. PubMed ID: 30726148
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program.
    Vlahov D; Junge B; Brookmeyer R; Cohn S; Riley E; Armenian H; Beilenson P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(5):400-6. PubMed ID: 9420320
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model.
    Lee CSJ; Mateu-Gelabert P; Melendez YA; Fong C; Kapadia SN; Smith M; Marks KM; Eckhardt B
    PLoS One; 2024; 19(8):e0308102. PubMed ID: 39208211
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Factors associated with readiness to change drug use among needle-exchange users.
    Bluthenthal RN; Gogineni A; Longshore D; Stein M
    Drug Alcohol Depend; 2001 May; 62(3):225-30. PubMed ID: 11295327
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Addiction treatment: promoting a medical approach to substance use.
    Stein GL; Fleischman AR
    J Urban Health; 1998 Sep; 75(3):558-83. PubMed ID: 9762650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.